Innovations and Challenges in the Treatment of Metastatic Triple-Negative Breast Cancer

被引：3
作者：
McArthur, Heather L. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
JOURNAL OF ONCOLOGY PRACTICE | 2018年 / 14卷 / 05期
关键词：
D O I：
10.1200/JOP.18.00224
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：290 / +
页数：3
相关论文
共 10 条
  • [1] Phase Ib trial of atezolizumab in combination with nab-paclitaxel in patients with metastatic triple negative breast cancer (mTNBC).
    Adams, Sylvia
    Diamond, Jennifer Robinson
    Hamilton, Erika Paige
    Pohlmann, Paula Raffin
    Tolaney, Sara M.
    Molinero, Luciana
    He, Xian
    Waterkamp, Daniel
    Funke, Roel Peter
    Powderly, John D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
    Andre, Fabrice
    Bachelot, Thomas
    Commo, Frederic
    Campone, Mario
    Arnedos, Monica
    Dieras, Veronique
    Lacroix-Triki, Magali
    Lacroix, Ludovic
    Cohen, Pascale
    Gentien, David
    Adelaide, Jose
    Dalenc, Florence
    Goncalves, Anthony
    Levy, Christelle
    Ferrero, Jean-Marc
    Bonneterre, Jacques
    Lefeuvre, Claudia
    Jimenez, Marta
    Filleron, Thomas
    Bonnefoi, Herve
    [J]. LANCET ONCOLOGY, 2014, 15 (03) : 267 - 274
  • [3] Are There Any Clinically Relevant Subgroups of Triple-Negative Breast Cancer in 2018?
    Chan, Jack J.
    Tan, Tira J. Y.
    Dent, Rebecca A.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (05) : 281 - +
  • [4] Physician-Related Factors Involved in Patient Decisions to Enroll Onto Cancer Clinical Trials
    Comis, Robert L.
    Miller, Jon D.
    Colaizzi, Diane D.
    Kimmel, Linda G.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2009, 5 (02) : 50 - 56
  • [5] Litton J, 2017, 2016 SAN ANT BREAST
  • [6] Perou CM, 2016, 2016 SAN ANT BREAST
  • [7] Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
    Robson, Mark
    Im, Seock-Ah
    Senkus, Elzbieta
    Xu, Binghe
    Domchek, Susan M.
    Masuda, Norikazu
    Delaloge, Suzette
    Li, Wei
    Tung, Nadine
    Armstrong, Anne
    Wu, Wenting
    Goessl, Carsten
    Runswick, Sarah
    Conte, Pierfranco
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (06) : 523 - 533
  • [8] Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing
    Sharma, Priyanka
    Klemp, Jennifer R.
    Kimler, Bruce F.
    Mahnken, Jonathan D.
    Geier, Larry J.
    Khan, Qamar J.
    Elia, Manana
    Connor, Carol S.
    McGinness, Marilee K.
    Mammen, Joshua M. W.
    Wagner, Jamie L.
    Ward, Claire
    Ranallo, Lori
    Knight, Catherine J.
    Stecklein, Shane R.
    Jensen, Roy A.
    Fabian, Carol J.
    Godwin, Andrew K.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (03) : 707 - 714
  • [9] Phase 2 study and correlative analyses of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic, triple-negative breast cancer
    Stover, Daniel G.
    Del Alcazar, Carlos R. Gil
    Tolaney, Sara M.
    Bardia, Aditya
    Guo, Hao
    Balko, Justin M.
    Overmoyer, Beth A.
    Gelman, Rebecca S.
    Lloyd, Max
    Wang, Vivian
    Brock, Jane E.
    Winer, Eric P.
    Polyak, Kornelia
    Lin, Nancy U.
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [10] Tutt A, 2014, SAN ANTONIO BREAST C, V2014, pS3
1